Pursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- "Wockhardt submits new drug Application to U.S. FDA for Zidebactam-Cefepime (WCK 5222) for Treatment of serious Gram-Negative Infections".
Wockhardt: Announcement under Regulation 30 (LODR)-Press Release / Media Release
October 1, 2025
Download PDF
Wockhardt